E. Connolly-Strong

发表

Treatment Patterns and Health Care Costs of Lupus Nephritis in a United States Payer Population

W. Nelson, A. Edwards, A. Sanyal, 2020, Open access rheumatology : research and reviews.

Patient-reported flare frequency is associated with diminished quality of life and family role functioning in systemic lupus erythematosus

P. Katz, G. Wan, M. Reed, 2020, Quality of Life Research.

Improvement in clinical disease activity index when treatment selection is informed by the tumor necrosis factor-ɑ inhibitor molecular signature response classifier: analysis from the study to accelerate information of molecular signatures in rheumatoid arthritis

V. Strand, Lixia Zhang, E. Connolly-Strong, 2022, Expert opinion on biological therapy.

Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rheumatoid arthritis

Stanley B. Cohen, V. Strand, J. Curtis, 2021, Expert review of molecular diagnostics.

Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial

R. Furie, A. Askanase, Enxu Zhao, 2020, Lupus Science & Medicine.

The ALPHA Project: Establishing consensus and prioritisation of global community recommendations to address major challenges in lupus diagnosis, care, treatment and research

I. Bruce, B. Rovin, K. Kalunian, 2021, Lupus Science & Medicine.

Melanocortin Peptides: Potential Targets in Systemic Lupus Erythematosus

S. Sturgill‐Koszycki, L. Loram, E. Connolly-Strong, 2014, Inflammation.

Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utility

C. Arnell, M. Bergman, J. Kenney, 2021, Journal of managed care & specialty pharmacy.

A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study

J. Kremer, S. Ghiassian, D. Pappas, 2021, Rheumatology and Therapy.

Patient-Reported Lupus Flare Symptoms Are Associated with Worsened Patient Outcomes and Increased Economic Burden.

W. Nelson, P. Katz, M. Reed, 2020, Journal of managed care & specialty pharmacy.

Digital Commons@Becker Digital Commons@Becker

Jingyu Liu, J. Liu, J. Zhu, 2022 .

Digital Commons@Becker Digital Commons@Becker

Jingyu Liu, J. Liu, J. Zhu, 2022 .